Work With Data
live In the news:
Biogen partner Eisai cut US jobs. Now can it boost Alzheimer's drug sales? / Sage Therapeutics Jumps on Biogen's $469 Million Takeover Offer / European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai / Stocks making the biggest moves midday: JetBlue Airways, Shopify, Biogen and more / Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies

Biogen

Updated: 136d ago

Biogen is a company. It is a private company.

Key facts

  • employees: 291 people
  • revenues: 21M $
  • company type: private
  • ESG score: 78.41 / 100
plus See more facts

Extract data

Download datasets about Biogen:

dataset Dataset of stocks from Biogen

Biogen is one of the 3,456,808 companies in our database.

Talking Points

  • Loading...

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.